Pharmaceutical Salt Formation as a Strategy to Enhance In Situ Drug Loading into Apatite-Based Materials
5 affiliations
- 1Istituto per lo Studio dei Materiali Nanostrutturati (ISMN)-Consiglio Nazionale Delle Ricerche (CNR) , Via P. Gobetti 101 , ,
- 2Hospital Universitario Virgen de las Nieves , , ,
- 3University of Granada , , ,
- 4Universitat de les Illes Balears , , Crta. de Valldemossa km 7.5 , ,
- 5IACT-CSIC , , Avda. de las Palmeras 4 , ,
Abstract
Water-based loading is attractive for pharmaceutical and industrial applications and helps prevent damage to drug carriers; however, the poor aqueous solubility of many APIs, such as ciprofloxacin (CIP), limits their incorporation into these systems. To overcome these limitations, this work explores the use of a ciprofloxacin–dexketoprofen (CIP–DKT) pharmaceutical salt to improve API solubility and in situ loading into sensitive apatite platforms, including biomimetic apatite nanoparticles (Ap) and apatite-mineralized eggshell membranes (ApESM). Computational and solid-state characterization rationalized the improved aqueous solubility and drug loading observed with CIP–DKT. CIP showed higher affinity for the negatively charged apatite surface, whereas DKT displayed lower affinity and, due to its acidic nature, altered the synthesis pH, affecting apatite morphology and ESM mineralization. Interestingly, CIP–DKT enabled the simultaneous incorporation of CIP and DKT while preserving the biomimetic apatite morphology and the mineralization of the ESMs, likely due to the buffering effect of CIP. Final HPLC and antibacterial assays confirmed pH-dependent API release and sustained antibacterial activity against Escherichia coli, with improved diffusion from ApESM–CIP–DKT. Overall, these results demonstrate that pharmaceutical salt formation is an efficient strategy to enhance the incorporation of poorly soluble APIs into sensitive materials under water-based processing conditions.
Related
- Development of an innovative method to enhance doxorubicin loading into erythrocyte-derived nanovesicles for breast cancer drug delivery
- Perspectives on the amorphisation/milling relationship in pharmaceutical materials
- Spinel Interphase Modulation in Ba/Al2O3: A Strategy to Enhance NO x Storage Capacity and Durability of NSR Catalysts
- A Review of Grain Boundaries: Formation Mechanism, Synthesis Strategy, and Application in Electrocatalysis
- Influence of Fiber Diameter and Surface Structure of Polycaprolactone Nanofibrous Materials on Yeast Retention and Biofilm Formation
BibTeX
@article{acebedomartinez2026pharmaceutical,
title = {{Pharmaceutical Salt Formation as a Strategy to Enhance In Situ Drug Loading into Apatite-Based Materials}},
author = {Francisco Javier Acebedo-Martínez and Carolina Alarcón-Payer and Alicia Domínguez-Martín and Antonio Frontera and Jaime Gómez-Morales and Marisa M. Morales and Sara Rojas and Duane Choquesillo-Lazarte},
journal = {ACS Omega},
year = {2026},
month = nov,
doi = {10.1021/acsomega.6c08821},
url = {https://pubs.acs.org/acsodf/article/doi/10.1021/acsomega.6c08821/5466016/Pharmaceutical-Salt-Formation-as-a-Strategy-to},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Pharmaceutical Salt Formation as a Strategy to Enhance In Situ Drug Loading into Apatite-Based Materials
AU - Francisco Javier Acebedo-Martínez
AU - Carolina Alarcón-Payer
AU - Alicia Domínguez-Martín
AU - Antonio Frontera
AU - Jaime Gómez-Morales
AU - Marisa M. Morales
AU - Sara Rojas
AU - Duane Choquesillo-Lazarte
PY - 2026
DA - 2026/11/06
JO - ACS Omega
DO - 10.1021/acsomega.6c08821
UR - https://pubs.acs.org/acsodf/article/doi/10.1021/acsomega.6c08821/5466016/Pharmaceutical-Salt-Formation-as-a-Strategy-to
AB - Water-based loading is attractive for pharmaceutical and industrial applications and helps prevent damage to drug carriers; however, the poor aqueous solubility of many APIs, such as ciprofloxacin (CIP), limits their incorporation into these systems. To overcome these limitations, this work explores the use of a ciprofloxacin–dexketoprofen (CIP–DKT) pharmaceutical salt to improve API solubility and in situ loading into sensitive apatite platforms, including biomimetic apatite nanoparticles (Ap) and apatite-mineralized eggshell membranes (ApESM). Computational and solid-state characterization rationalized the improved aqueous solubility and drug loading observed with CIP–DKT. CIP showed higher affinity for the negatively charged apatite surface, whereas DKT displayed lower affinity and, due to its acidic nature, altered the synthesis pH, affecting apatite morphology and ESM mineralization. Interestingly, CIP–DKT enabled the simultaneous incorporation of CIP and DKT while preserving the biomimetic apatite morphology and the mineralization of the ESMs, likely due to the buffering effect of CIP. Final HPLC and antibacterial assays confirmed pH-dependent API release and sustained antibacterial activity against Escherichia coli, with improved diffusion from ApESM–CIP–DKT. Overall, these results demonstrate that pharmaceutical salt formation is an efficient strategy to enhance the incorporation of poorly soluble APIs into sensitive materials under water-based processing conditions.
SN - 2470-1343
ER -